World News ·
Goldman Sachs reiterates Summit Therapeutics stock rating on AstraZeneca deal
Source: investing.com
More from World News
- Man City CEO defiant over Premier League charges
- Bigger than CRISPR? A guide to the latest genome editors
- Vaping in childhood has bigger health risks than we’d thought
- ‘Football with a smile’: Pocognoli wants happy Gilmour to tee up Scotland success
- Apple ordered to pay $5.7bn after losing vibration tech patent suit
- 38-year-old backup Case Keenum rolls back the years to lead Bears past Eagles
- Temperatures to hit 25C in burst of late September warmth
- Hollyoaks' Leah rushed to hospital as Lucas stand-off ends in disaster
- BBC unveils first look at "masterpiece" spy thriller from the team behind The Night Manag…
- Coronation Street's Kit Green to shock Lisa with cancer news
- Did Trump reveal secret US-UK operation over RAF Fairford incident?
- Stalemate over Orange Order parade - as solution to dispute 'tantalisingly a bit far away'
You are seeing a public preview. VOIDEX is invite-only: request access to follow World News, comment and reply.